Antiepileptics raise pneumonia risk among Alzheimer's patients, study says

21 March 2019
alzheimer-s-big

People with Alzheimer’s who use the antiepileptic drugs phenytoin, carbamazepine, valproic acid and pregabalin were associated with an increased risk of pneumonia.

Those are the findings of a study from the University of Eastern Finland, which has been published in the Journal of Alzheimer’s Disease.

The risk was highest in the beginning of use, but remained on an elevated level even in long-term use, the research found.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Biotechnology